How do you compare two GLP-1 providers fairly?

Match the product first. A channel selling a Wegovy pill and a channel selling a Wegovy pen are not offering the same thing, so their headline prices are not a price difference. Compare the same drug in the same form, take each channel’s cheapest published dose for it, and add any required membership fee, because the fee is not optional.

Why do some providers show no monthly price?

Because they do not publish one. Some price only on an annual commitment, and some charge a program fee and bill medication separately at whatever the pharmacy or insurer charges. We leave the figure blank rather than inventing a monthly equivalent from an annual rate.

Tools

Compare any two channels

120 possible head-to-heads from the 16 channels we track. Pick two and the same dataset that powers the index lays them out side by side — matched on drug and form, all-in, with the fees included.

Listed prices researched 2026-09-04 · how we verify · the full index

Pick two

Channel A Channel B

How the matching works

Same drug, same form, or no verdict. Hims' headline is a Wegovy pill at $298 all-in; Ro's is a Wegovy pen at $498. Putting those two numbers next to each other looks like a $200 gap and is really a pill against a pen. This tool matches products first and only compares within a match. Where two channels share nothing comparable, it says so instead of picking a winner.
All-in means the fee is in. Where a membership is required to buy at all, it is part of the price, so it is added to every dose tier. Ro's $149/mo is not a separate decision from Ro's medication.
Cheapest published dose, not the headline. Each side uses its own lowest published tier for the matched product. Your dose may be higher — the titration projector walks a full ladder.
Month-to-month against month-to-month. Cora's compounded semaglutide is $175 monthly or $99 on a $1,188 annual prepay. Comparing that $99 against a rival's cancel-anytime price would hand the win to whoever demands the longest contract. Annual rates appear in the table, labelled, and stay out of the verdict. A channel that publishes nothing but annual pricing — Trimi — has no monthly figure here at all, the same call the index makes.
Blank is blank. We do not divide an annual price by twelve and present it as a monthly one, and we do not estimate a medication cost for the programs that bill it separately.

What this is not. It is not clinical guidance and not a recommendation of a provider. Which drug is right for you, at what dose, and whether any of these is appropriate at all are questions for a licensed clinician. Prices are listed prices on the researched date; the checkout is the final word.

Pricing tool, not medical advice. Listed prices on the researched date; a checkmark means we walked that row to checkout, and everything else is the provider's own published figure. Required fees are included in every all-in number. Some links may earn commissions; nothing here is ordered by compensation — disclosure.